Philip Morris has an incredible plan to promote the Juicero of Vapes



[ad_1]

Photo: Sebastian Reuter (Getty)

The cigarette has experienced a historic decline in the United States. This leaves tobacco conglomerates a little less profitable the opportunity to prove once again that they are perverse and stupid. "What all smokers need – the people we slowly make sick and die – need it," you can almost imagine a costume wondering aloud in Philip Morris's conference room. Health insurance!

As for the good argument of any good supporter, wait, there is more. Reviti, the name of this dubious insurance company, specifically and disproportionately rewards policyholders who give up cigarettes for Philip Morris International's bizarre iQOS system (PMI). The price will be full for smokers and halfway for people who quit, but in the medium term, those who stay with iQOS for three months or more will see their premiums reduced by 25%, compared to 2.5% for the other electronic cigarette system, including those that PMI sells itself.

Beyond the pretty bald profiteers integrated into this structure, the problem is that the iQOS is perhaps one of the least well designed products since Juicero. It is really disconcerting that something so serious exists. Instead of a liquid containing nicotine, as in electronic cigarettes, iQOS capsules (called, I do not bother you, "Heets") are … a half-cigarette.

The future is now.

Instead of burning what is very clearly a paper tube stuffed with chopped tobacco leaves, the iQOS heats miniature cigs to a temperature producing steam. "Because tobacco is heated and not burned," says PMI on its website, "the levels of harmful chemicals are significantly reduced compared to cigarette smoke".

According to a study that attempted to verify the safety assertions of PMI, 56 harmful or potentially harmful components (HPHC) were tested more effectively in iQOS than traditional cigarettes, some astronomically. Dr. Stanton Glantz, director of the Center for Tobacco Research and Control, also wrote that "iQOS is" as likely as smoking "and" generates significant lung damage ".

iQOS has not yet received FDA approval for sale in the United States.

Does it make sense to associate discounts on products with the use of an expensive and oversized cigarette robot whose health effects are far from understood? "This is obviously logical for public health and smokers, but also for our shareholders because, financially, these products are not cigarettes," Andre Calantzopoulos, CEO of PMI, told CNBC at the margins, so Is a win-win for everyone. "

PMI was not immediately available for comment.

[CNBC]

[ad_2]

Source link